Results 1 to 10 of about 7,413 (79)

Inclusion body myositis. [PDF]

CMAJ
Warman-Chardon J, Breiner A, Bourque PR.
europepmc   +5 more sources

Inclusion Body Myositis [PDF]

Neurologic Clinics, 2012
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare disorders that share many similarities. In addition to sporadic inclusion body myositis (IBM), these include dermatomyositis, polymyositis, and autoimmune necrotizing myopathy. IBM is the most common IIM after age 50 years.
Mazen M, Dimachkie, Richard J, Barohn
  +9 more sources

Inclusion body myositis [PDF]

Current Opinion in Rheumatology, 2002
Inclusion body myositis (IBM) is an inflammatory myopathy with distinctive clinicopathologic features. The etiology of IBM remains elusive. The immune-mediated basis for this disease has been challenged by evidence implicating a number of divergent etiologic factors.
Rabi, Tawil, Robert C, Griggs
openaire   +4 more sources

Inclusion body myositis

Current Opinion in Rheumatology, 2011
Sporadic inclusion body myositis (sIBM) is a poorly understood immune and degenerative disease of skeletal muscle. Here, current opinion of the nature of this disease is summarized.Recent findings for sIBM include further characterization of muscle involvement through magnetic resonance imaging, the role of muscle as a host for immune cells, progress ...
Ivanidze, Jana, Hoffmann, Reinhard, Lochmüller, Hanns, Engel, Andrew G., Hohlfeld, Reinhard, Dornmair, Klaus   +5 more
  +7 more sources

Genetics in inclusion body myositis [PDF]

Current Opinion in Rheumatology, 2017
Purpose of review To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year. Recent findings One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen
Rothwell, Simon, Lilleker, James, Lamb, Janine   +2 more
openaire   +3 more sources

[Inclusion body myositis]. [PDF]

Presse medicale (Paris, France : 1983), 1996
Inclusion body myositis has been recently recognized as a clinical entity although its exact definition remains uncertain. Initially considered to be an inflammatory dermatomyositis, inclusion body myositis can actually take on three specific forms: disseminated muscle atrophy and weakness, pseudopolymyositis, or pseudo-degenerative disease.
Garlepp, M.J., Mastaglia, F.L.
openaire   +4 more sources

Inclusion Body Myositis [PDF]

, 2020
Schmidt, Karsten, Schmidt, Jens
  +6 more sources

Electromyography varies by stage in inclusion body myositis. [PDF]

Front Neurol, 2023
Mano T, Iguchi N, Eura N, Iwasa N, Yamada N, Horikawa H, Sugie K.   +6 more
europepmc   +1 more source

The Myositis Overlap Conundrum: Differentiating Polymyositis from Inclusion Body Myositis. [PDF]

Juntendo Med J
Hein M, Aung WLL, Thu EM, Huda AA.
europepmc   +1 more source

Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology. [PDF]

Acta Neuropathol Commun
Kleefeld F, Schroeter CB, Abdennebi D, Dobelmann V, Walli S, Roos A, Distler U, Tenzer S, Bopp T, Quint P, Schmitt LI, Leo M, Hagenacker T, Pinal-Fernandez I, Casal-Dominguez M, Mammen AL, Preuße C, Maggi L, Mensch A, Meuth SG, Stenzel W, Ruck T, Nelke C.   +22 more
europepmc   +1 more source